Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Biopharmaceutical is a pharmaceutical derived from biological sources and especially one produced by biotechnology. A vaccine is a biological preparation that provides active acquired immunity to a particular disease.
Biopharmaceutical and Vaccine Production market report explains the definition, types, applications, major countries, and major players of the Biopharmaceutical and Vaccine Production market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Alexion Pharmaceuticals
Merck
GlaxoSmithKline
Novartis
Pfizer
Johnson and Johnson
Sanofi
Abbott
Lonza and FUJIFILM Diosynth Biotechnologies
Roche
Regeneron Pharmaceuticals
By Type:
Biopharmaceutical
Vaccine Production
By End-User:
Pharmaceutical
Biotechnology
Academic and Research Institutes
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Biopharmaceutical and Vaccine Production Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Biopharmaceutical and Vaccine Production Outlook to 2028- Original Forecasts
-
2.2 Biopharmaceutical and Vaccine Production Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Biopharmaceutical and Vaccine Production Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Biopharmaceutical and Vaccine Production Market- Recent Developments
-
6.1 Biopharmaceutical and Vaccine Production Market News and Developments
-
6.2 Biopharmaceutical and Vaccine Production Market Deals Landscape
7 Biopharmaceutical and Vaccine Production Raw Materials and Cost Structure Analysis
-
7.1 Biopharmaceutical and Vaccine Production Key Raw Materials
-
7.2 Biopharmaceutical and Vaccine Production Price Trend of Key Raw Materials
-
7.3 Biopharmaceutical and Vaccine Production Key Suppliers of Raw Materials
-
7.4 Biopharmaceutical and Vaccine Production Market Concentration Rate of Raw Materials
-
7.5 Biopharmaceutical and Vaccine Production Cost Structure Analysis
-
7.5.1 Biopharmaceutical and Vaccine Production Raw Materials Analysis
-
7.5.2 Biopharmaceutical and Vaccine Production Labor Cost Analysis
-
7.5.3 Biopharmaceutical and Vaccine Production Manufacturing Expenses Analysis
8 Global Biopharmaceutical and Vaccine Production Import and Export Analysis (Top 10 Countries)
-
8.1 Global Biopharmaceutical and Vaccine Production Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Biopharmaceutical and Vaccine Production Export by Region (Top 10 Countries) (2017-2028)
9 Global Biopharmaceutical and Vaccine Production Market Outlook by Types and Applications to 2022
-
9.1 Global Biopharmaceutical and Vaccine Production Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Vaccine Production Consumption and Growth Rate (2017-2022)
-
9.2 Global Biopharmaceutical and Vaccine Production Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Pharmaceutical Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Biotechnology Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Academic and Research Institutes Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Biopharmaceutical and Vaccine Production Market Analysis and Outlook till 2022
-
10.1 Global Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.2.2 Canada Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.2.3 Mexico Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.3.2 UK Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.3.3 Spain Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.3.4 Belgium Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.3.5 France Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.3.6 Italy Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.3.7 Denmark Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.3.8 Finland Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.3.9 Norway Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.3.10 Sweden Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.3.11 Poland Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.3.12 Russia Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.3.13 Turkey Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.4.2 Japan Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.4.3 India Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.4.4 South Korea Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.4.5 Pakistan Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.4.6 Bangladesh Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.4.7 Indonesia Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.4.8 Thailand Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.4.9 Singapore Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.4.10 Malaysia Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.4.11 Philippines Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.4.12 Vietnam Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.5.2 Colombia Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.5.3 Chile Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.5.4 Argentina Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.5.5 Venezuela Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.5.6 Peru Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.5.7 Puerto Rico Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.5.8 Ecuador Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.6.2 Kuwait Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.6.3 Oman Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.6.4 Qatar Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.6.5 Saudi Arabia Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.6.6 United Arab Emirates Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.7.2 South Africa Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.7.3 Egypt Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.7.4 Algeria Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Biopharmaceutical and Vaccine Production Consumption (2017-2022)
-
10.8.2 New Zealand Biopharmaceutical and Vaccine Production Consumption (2017-2022)
11 Global Biopharmaceutical and Vaccine Production Competitive Analysis
-
11.1 Alexion Pharmaceuticals
-
11.1.1 Alexion Pharmaceuticals Company Details
-
11.1.2 Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Main Business and Markets Served
-
11.1.4 Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Merck
-
11.2.1 Merck Company Details
-
11.2.2 Merck Biopharmaceutical and Vaccine Production Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Merck Biopharmaceutical and Vaccine Production Main Business and Markets Served
-
11.2.4 Merck Biopharmaceutical and Vaccine Production Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 GlaxoSmithKline
-
11.3.1 GlaxoSmithKline Company Details
-
11.3.2 GlaxoSmithKline Biopharmaceutical and Vaccine Production Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 GlaxoSmithKline Biopharmaceutical and Vaccine Production Main Business and Markets Served
-
11.3.4 GlaxoSmithKline Biopharmaceutical and Vaccine Production Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Novartis
-
11.4.1 Novartis Company Details
-
11.4.2 Novartis Biopharmaceutical and Vaccine Production Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Novartis Biopharmaceutical and Vaccine Production Main Business and Markets Served
-
11.4.4 Novartis Biopharmaceutical and Vaccine Production Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Pfizer
-
11.5.1 Pfizer Company Details
-
11.5.2 Pfizer Biopharmaceutical and Vaccine Production Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Pfizer Biopharmaceutical and Vaccine Production Main Business and Markets Served
-
11.5.4 Pfizer Biopharmaceutical and Vaccine Production Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Johnson and Johnson
-
11.6.1 Johnson and Johnson Company Details
-
11.6.2 Johnson and Johnson Biopharmaceutical and Vaccine Production Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Johnson and Johnson Biopharmaceutical and Vaccine Production Main Business and Markets Served
-
11.6.4 Johnson and Johnson Biopharmaceutical and Vaccine Production Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Sanofi
-
11.7.1 Sanofi Company Details
-
11.7.2 Sanofi Biopharmaceutical and Vaccine Production Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Sanofi Biopharmaceutical and Vaccine Production Main Business and Markets Served
-
11.7.4 Sanofi Biopharmaceutical and Vaccine Production Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Abbott
-
11.8.1 Abbott Company Details
-
11.8.2 Abbott Biopharmaceutical and Vaccine Production Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Abbott Biopharmaceutical and Vaccine Production Main Business and Markets Served
-
11.8.4 Abbott Biopharmaceutical and Vaccine Production Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Lonza and FUJIFILM Diosynth Biotechnologies
-
11.9.1 Lonza and FUJIFILM Diosynth Biotechnologies Company Details
-
11.9.2 Lonza and FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Lonza and FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Main Business and Markets Served
-
11.9.4 Lonza and FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Roche
-
11.10.1 Roche Company Details
-
11.10.2 Roche Biopharmaceutical and Vaccine Production Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Roche Biopharmaceutical and Vaccine Production Main Business and Markets Served
-
11.10.4 Roche Biopharmaceutical and Vaccine Production Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Regeneron Pharmaceuticals
-
11.11.1 Regeneron Pharmaceuticals Company Details
-
11.11.2 Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Main Business and Markets Served
-
11.11.4 Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Product Portfolio
-
11.11.5 Recent Research and Development Strategies
12 Global Biopharmaceutical and Vaccine Production Market Outlook by Types and Applications to 2028
-
12.1 Global Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Biotechnology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Academic and Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Biopharmaceutical and Vaccine Production Market Analysis and Outlook to 2028
-
13.1 Global Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.2.2 Canada Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.2.3 Mexico Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.3.2 UK Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.3.3 Spain Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.3.4 Belgium Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.3.5 France Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.3.6 Italy Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.3.7 Denmark Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.3.8 Finland Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.3.9 Norway Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.3.10 Sweden Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.3.11 Poland Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.3.12 Russia Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.3.13 Turkey Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.4.2 Japan Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.4.3 India Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.4.4 South Korea Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.4.8 Thailand Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.4.9 Singapore Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.4.11 Philippines Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.5.2 Colombia Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.5.3 Chile Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.5.4 Argentina Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.5.6 Peru Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.6.3 Oman Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.6.4 Qatar Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.7.2 South Africa Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.7.3 Egypt Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.7.4 Algeria Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Biopharmaceutical and Vaccine Production Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Biopharmaceutical and Vaccine Production
-
Figure of Biopharmaceutical and Vaccine Production Picture
-
Table Global Biopharmaceutical and Vaccine Production Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Biopharmaceutical and Vaccine Production Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Global Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Global Biotechnology Consumption and Growth Rate (2017-2022)
-
Figure Global Academic and Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Biopharmaceutical and Vaccine Production Consumption by Country (2017-2022)
-
Table North America Biopharmaceutical and Vaccine Production Consumption by Country (2017-2022)
-
Figure United States Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Canada Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Mexico Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Table Europe Biopharmaceutical and Vaccine Production Consumption by Country (2017-2022)
-
Figure Germany Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure UK Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Spain Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Belgium Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure France Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Italy Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Denmark Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Finland Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Norway Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Sweden Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Poland Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Russia Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Turkey Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Table APAC Biopharmaceutical and Vaccine Production Consumption by Country (2017-2022)
-
Figure China Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Japan Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure India Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure South Korea Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Thailand Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Singapore Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Philippines Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Table South America Biopharmaceutical and Vaccine Production Consumption by Country (2017-2022)
-
Figure Brazil Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Colombia Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Chile Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Argentina Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Peru Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Table GCC Biopharmaceutical and Vaccine Production Consumption by Country (2017-2022)
-
Figure Bahrain Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Oman Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Qatar Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Table Africa Biopharmaceutical and Vaccine Production Consumption by Country (2017-2022)
-
Figure Nigeria Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure South Africa Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Egypt Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Algeria Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Table Oceania Biopharmaceutical and Vaccine Production Consumption by Country (2017-2022)
-
Figure Australia Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Biopharmaceutical and Vaccine Production Consumption and Growth Rate (2017-2022)
-
Table Alexion Pharmaceuticals Company Details
-
Table Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Main Business and Markets Served
-
Table Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Product Portfolio
-
Table Merck Company Details
-
Table Merck Biopharmaceutical and Vaccine Production Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Biopharmaceutical and Vaccine Production Main Business and Markets Served
-
Table Merck Biopharmaceutical and Vaccine Production Product Portfolio
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Biopharmaceutical and Vaccine Production Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Biopharmaceutical and Vaccine Production Main Business and Markets Served
-
Table GlaxoSmithKline Biopharmaceutical and Vaccine Production Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Biopharmaceutical and Vaccine Production Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Biopharmaceutical and Vaccine Production Main Business and Markets Served
-
Table Novartis Biopharmaceutical and Vaccine Production Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Biopharmaceutical and Vaccine Production Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Biopharmaceutical and Vaccine Production Main Business and Markets Served
-
Table Pfizer Biopharmaceutical and Vaccine Production Product Portfolio
-
Table Johnson and Johnson Company Details
-
Table Johnson and Johnson Biopharmaceutical and Vaccine Production Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson and Johnson Biopharmaceutical and Vaccine Production Main Business and Markets Served
-
Table Johnson and Johnson Biopharmaceutical and Vaccine Production Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Biopharmaceutical and Vaccine Production Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Biopharmaceutical and Vaccine Production Main Business and Markets Served
-
Table Sanofi Biopharmaceutical and Vaccine Production Product Portfolio
-
Table Abbott Company Details
-
Table Abbott Biopharmaceutical and Vaccine Production Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Biopharmaceutical and Vaccine Production Main Business and Markets Served
-
Table Abbott Biopharmaceutical and Vaccine Production Product Portfolio
-
Table Lonza and FUJIFILM Diosynth Biotechnologies Company Details
-
Table Lonza and FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lonza and FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Main Business and Markets Served
-
Table Lonza and FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Product Portfolio
-
Table Roche Company Details
-
Table Roche Biopharmaceutical and Vaccine Production Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Biopharmaceutical and Vaccine Production Main Business and Markets Served
-
Table Roche Biopharmaceutical and Vaccine Production Product Portfolio
-
Table Regeneron Pharmaceuticals Company Details
-
Table Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Main Business and Markets Served
-
Table Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Product Portfolio
-
Figure Global Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biotechnology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Academic and Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biopharmaceutical and Vaccine Production Consumption Forecast by Country (2022-2028)
-
Table North America Biopharmaceutical and Vaccine Production Consumption Forecast by Country (2022-2028)
-
Figure United States Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Biopharmaceutical and Vaccine Production Consumption Forecast by Country (2022-2028)
-
Figure Germany Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Biopharmaceutical and Vaccine Production Consumption Forecast by Country (2022-2028)
-
Figure China Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Biopharmaceutical and Vaccine Production Consumption Forecast by Country (2022-2028)
-
Figure Brazil Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Biopharmaceutical and Vaccine Production Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Biopharmaceutical and Vaccine Production Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Biopharmaceutical and Vaccine Production Consumption Forecast by Country (2022-2028)
-
Figure Australia Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Biopharmaceutical and Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
